Huang C, Ogawa R
Int J Mol Sci. 2022; 23(12).
PMID: 35743263
PMC: 9223684.
DOI: 10.3390/ijms23126820.
Sepulveda-Crespo D, Resino S, Martinez I
Drugs. 2021; 81(4):419-443.
PMID: 33400242
DOI: 10.1007/s40265-020-01458-x.
Dakhlallah D, Wang Y, Bobo T, Ellis E, Mo X, Piper M
Adv Biosci Biotechnol. 2019; 10(10):346-373.
PMID: 31750010
PMC: 6866236.
DOI: 10.4236/abb.2019.1010027.
Dong J, Ma Q
Nanotoxicology. 2019; 13(9):1244-1274.
PMID: 31537143
PMC: 6803058.
DOI: 10.1080/17435390.2019.1651920.
Dong J, Ma Q
Part Fibre Toxicol. 2016; 13(1):60.
PMID: 27814727
PMC: 5097370.
DOI: 10.1186/s12989-016-0172-2.
Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.
Huang L, Fu P, Patel P, Harijith A, Sun T, Zhao Y
Am J Respir Cell Mol Biol. 2013; 49(6):912-22.
PMID: 23808384
PMC: 3931116.
DOI: 10.1165/rcmb.2013-0070OC.
Host responses in tissue repair and fibrosis.
Duffield J, Lupher M, Thannickal V, Wynn T
Annu Rev Pathol. 2012; 8:241-76.
PMID: 23092186
PMC: 3789589.
DOI: 10.1146/annurev-pathol-020712-163930.
Determinants of initiation and progression of idiopathic pulmonary fibrosis.
Kottmann R, Hogan C, Phipps R, Sime P
Respirology. 2009; 14(7):917-33.
PMID: 19740254
PMC: 3884519.
DOI: 10.1111/j.1440-1843.2009.01624.x.
Thalidomide has a therapeutic effect on interstitial lung fibrosis: evidence from in vitro and in vivo studies.
Zhao L, Xiao K, Wang H, Wang Z, Sun L, Zhang F
Clin Exp Immunol. 2009; 157(2):310-5.
PMID: 19604271
PMC: 2730857.
DOI: 10.1111/j.1365-2249.2009.03962.x.
Carbon monoxide modulates alpha-smooth muscle actin and small proline rich-1a expression in fibrosis.
Zheng L, Zhou Z, Lin L, Alber S, Watkins S, Kaminski N
Am J Respir Cell Mol Biol. 2008; 41(1):85-92.
PMID: 19097987
PMC: 2701963.
DOI: 10.1165/rcmb.2007-0401OC.
The Role of PPARs in Lung Fibrosis.
Lakatos H, Thatcher T, Kottmann R, Garcia T, Phipps R, Sime P
PPAR Res. 2007; 2007:71323.
PMID: 17710235
PMC: 1940051.
DOI: 10.1155/2007/71323.
Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.
Horowitz J, Thannickal V
Treat Respir Med. 2006; 5(5):325-42.
PMID: 16928146
PMC: 2231521.
DOI: 10.2165/00151829-200605050-00004.
Skeletal myosin heavy chain function in cultured lung myofibroblasts.
Rice N, Leinwand L
J Cell Biol. 2003; 163(1):119-29.
PMID: 14557251
PMC: 2173446.
DOI: 10.1083/jcb.200303194.
Structural and functional changes in heparan sulfate proteoglycan expression associated with the myofibroblastic phenotype.
Thomas G, Clayton A, Thomas J, Davies M, Steadman R
Am J Pathol. 2003; 162(3):977-89.
PMID: 12598330
PMC: 3278775.
DOI: 10.1016/S0002-9440(10)63892-8.
Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching.
Chambers R, Leoni P, Kaminski N, Laurent G, Heller R
Am J Pathol. 2003; 162(2):533-46.
PMID: 12547711
PMC: 1851161.
DOI: 10.1016/s0002-9440(10)63847-3.
Peplomycin, a bleomycin derivative, induces myofibroblasts in pulmonary fibrosis.
Osaki T, Yoneda K, Tatemoto Y, Yamamoto T, Yokoyama T, Enzan H
Int J Exp Pathol. 2001; 82(4):231-41.
PMID: 11493347
PMC: 2517715.
DOI: 10.1111/j.1365-2613.2001.iep0082-0231-x.
Lung fibrosis.
Fonseca C, Abraham D, Black C
Springer Semin Immunopathol. 2000; 21(4):453-74.
PMID: 10945036
DOI: 10.1007/s002810000036.
